Dana Farber Cancer Institute Dana 1B11

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Graft vs. Host Disease (GvHD)

Studies at this site

• Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant — Completed